First identified Korean family with Tatton-Brown-Rahman Syndrome caused by the novel DNMT3A variant c.118G>C p.(Glu40Gln)
10.6065/apem.2019.24.4.253
- Author:
Cha Gon LEE
1
;
Ja Hyun JANG
;
Ji Young SEO
Author Information
1. Department of Pediatrics, Nowon Eulji Medical Center, Eulji University, Seoul, Korea. pedseo@eulji.ac.kr
- Publication Type:Case Report
- Keywords:
DNMT3A;
Germ-line mutation;
Tatton-Brown-Rahman syndrome;
Growth disorder;
Intellectual disability;
High throughput nucleotide sequencing;
DNA sequence analysis
- MeSH:
Early Diagnosis;
Genetic Counseling;
Germ-Line Mutation;
Growth Disorders;
High-Throughput Nucleotide Sequencing;
Humans;
Intellectual Disability;
Megalencephaly;
Mothers;
Mutation, Missense;
Prevalence;
Sequence Analysis, DNA;
Wills
- From:Annals of Pediatric Endocrinology & Metabolism
2019;24(4):253-256
- CountryRepublic of Korea
- Language:English
-
Abstract:
Tatton-Brown-Rahman Syndrome (TBRS), an overgrowth syndrome caused by heterozygous mutation of DNMT3A, first was described in 2014. Approximately 60 DNMT3A variants, including 32 missense variants, have been reported, with most missense mutations located on the DNMT3A functional domains. Autosomal dominant inheritance by germ-line mutation of DNMT3A has been reported, but vertical transmission within a family is extremely rare. Herein, we report the first Korean family with maternally inherited TBRS due to the novel heterozygous DNMT3A variant c.118G>C p.(Glu40Gln), located outside the main functional domain and identified by multigene panel sequencing. The patient and her mother had typical clinical features, including tall stature during childhood, macrocephaly, intellectual disability, and characteristic facial appearance. TBRS shows milder dysmorphic features than other overgrowth syndromes, potentially leading to underdiagnosis and underestimated prevalence; thus, targeted multigene panel sequencing including DNMT3A will be a useful tool in cases of overgrowth and unexplained mild intellectual disability for early diagnosis and genetic counseling.
